Preprint · OA
via OpenAlex
Senolytic therapy preserves blood-brain barrier integrity and promotes microglia homeostasis in a tauopathy model
Minmin Yao, Zhiliang Wei, Jonathan Scharff Nielsen, Aaron Kakazu, Yuxiao Ouyang, Ruoxuan Li, Tiffany Chu, Susanna Scafidi, Hanzhang Lu, Manisha Aggarwal, Wenzhen Duan
bioRxiv (Cold Spring Harbor Laboratory) · 2024 · ▲ 1 citations
Abstract
Cellular senescence(definition), characterized by expressing the cell cycle inhibitory proteins, is evident in driving age-related diseases. Senescent cells play a crucial role in the initiation and progression of tau-mediated pathology, suggesting that targeting cell senescence offers a therapeutic potential for treating tauopathy associated diseases. This study focuses on identifying non-invasive biomarkers and validating their responses to a well-characterized senolytic therapy combining dasatinib and quercetin (D+Q), in a widely used tauopathy mouse model, PS19. We employed human-translatable MRI measures, including water extraction with phase-contrast arterial spin tagging (WEPCAST) MRI, T2 relaxation under spin tagging (TRUST), longitudinally assessed brain physiology and high-resolution structural MRI evaluated the brain regional volumes in PS19 mice. Our data reveal increased BBB permeability, decreased oxygen extraction fraction, and brain atrophy in 9-month-old PS19 mice compared to their littermate controls. (D+Q) treatment effectively preserves BBB integrity, rescues cerebral oxygen hypometabolism, attenuates brain atrophy, and alleviates tau hyperphosphorylation in PS19 mice. Mechanistically, D+Q treatment induces a shift of microglia from a disease-associated to a homeostatic state, reducing a senescence-like microglial phenotype marked by increased p16/INK4a. D+Q-treated PS19 mice exhibit enhanced cue-associated cognitive performance in the tracing fear conditioning test compared to the vehicle-treated littermates, implying improved cognitive function by D+Q treatment. Our results pave the way for application of senolytic treatment as well as these noninvasive MRI biomarkers in clinical trials in tauopathy associated neurological disorders.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1101/2024.03.25.586662
- Canonical
- link ↗
- Fetched
- 2026-10-08 MST
Cite this
APA
Yao, M., Wei, Z., Nielsen, J.S., Kakazu, A., Ouyang, Y., Li, R., Chu, T., Scafidi, S., Lu, H., Aggarwal, M., & Duan, W. (2024). Senolytic therapy preserves blood-brain barrier integrity and promotes microglia homeostasis in a tauopathy model. <em>bioRxiv (Cold Spring Harbor Laboratory)</em>. https://doi.org/10.1101/2024.03.25.586662
Vancouver
Yao M, Wei Z, Nielsen JS, Kakazu A, Ouyang Y, Li R, et al. Senolytic therapy preserves blood-brain barrier integrity and promotes microglia homeostasis in a tauopathy model. bioRxiv (Cold Spring Harbor Laboratory). 2024. doi:10.1101/2024.03.25.586662.
BibTeX
@unpublished{minmin2024Senoly,
title = {Senolytic therapy preserves blood-brain barrier integrity and promotes microglia homeostasis in a tauopathy model},
author = {Minmin Yao and Zhiliang Wei and Jonathan Scharff Nielsen and Aaron Kakazu and Yuxiao Ouyang and Ruoxuan Li and Tiffany Chu and Susanna Scafidi and Hanzhang Lu and Manisha Aggarwal and Wenzhen Duan},
journal = {bioRxiv (Cold Spring Harbor Laboratory)},
year = {2024},
doi = {10.1101/2024.03.25.586662},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Neurobiology of Disease 2024
Open access · CC-BY
Senolytic therapy preserves blood-brain barrier integrity and promotes microglia homeostasis in a tauopathy model
Science Translational Medicine 2023
Open access · OA
NKG2D-CAR T cells eliminate senescent cells in aged mice and nonhuman primates
EMBO Molecular Medicine 2026
Open access · CC-BY
Tomatidine is a senotherapeutic compound that improves cognitive function and reduces cellular senescence in aged mice
Pakistan Journal of Health Sciences 2024
Open access · CC-BY
Neuropharmacology of Fisetin as a Senotherapeutic Agent: Investigating Its Role in Neurodegeneration and Brain Aging
Cell Death and Disease 2022
Open access · CC-BY
Nintedanib induces senolytic effect via STAT3 inhibition
Scientific Reports 2022
Open access · CC-BY